Search Results

Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India: a retrospective cohort study.

• Authors : Kumar, Abhyuday¹; Kumar, Neeraj¹ ; Pattanayak, Arunima²

• Source: Acute & Critical Care. May2024, Vol. 39 Issue 2, p234-242. 9p.

Record details

Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study

• Authors : Akira Onishi; Masao Tanaka; Takayuki Fujii

Subjects: Rheumatoid arthritis; Antirheumatic agents; Interleukin-6 inhibitors

• Source: Arthritis Research & Therapy, Vol 27, Iss 1, Pp 1-11 (2025)

Record details

Staphylococcus aureus subcapsular splenic abscess and associated empyema in the setting of tocilizumab therapy: A case report.

• Authors : Lee, Audrey¹ (AUTHOR); Aw, Yi Tong Vincent^1,2,3 (AUTHOR)

• Source: Clinical Case Reports. Jun2024, Vol. 12 Issue 6, p1-5. 5p.

Record details

Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis.

• Authors : Dongmei Jia¹; Fenghe Zhang¹; Huining Li¹

• Source: Aging & Disease. Apr2024, Vol. 15 Issue 2, p824-830. 7p.

Record details

The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis.

• Authors : Ko, Ping-Hung^1,2 (AUTHOR) ; Kuo, Meng Hsuan³ (AUTHOR) ; Kao, I-Ting³ (AUTHOR)

Subjects: *HEPATITIS B virus; *DISEASE risk factors; *VIRUS reactivation

• Source: Viruses (1999-4915). Jan2024, Vol. 16 Issue 1, p78. 15p.

Record details

Tocilizumab treatment in MOGAD: a case report and literature review.

• Authors : Schirò, Giuseppe^1,2 (AUTHOR); Iacono, Salvatore^1,2 (AUTHOR); Andolina, Michele^1,2 (AUTHOR)

• Source: Neurological Sciences. Apr2024, Vol. 45 Issue 4, p1429-1436. 8p.

Record details

Over a decade of successful treatment with tocilizumab in a maintenance hemodialysis patient for Castleman disease: a case report and literature review

• Authors : Aya Shima; Takahiro Shima; Chie Matsuo

Subjects: Castleman disease; Maintenance hemodialysis; Tocilizumab

• Source: Renal Replacement Therapy, Vol 11, Iss 1, Pp 1-8 (2025)

Record details

Cytokine release syndrome treated with tocilizumab following ipilimumab–nivolumab combination therapy in advanced renal cell carcinoma

• Authors : Toru Inoue; Akiko Todaka; Masahiro Fuse

Subjects: cytokine release syndrome; immune checkpoint inhibitors; ipilimumab–nivolumab

• Source: IJU Case Reports, Vol 8, Iss 1, Pp 64-68 (2025)

Record details

Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study

• Authors : Yanxin Chen; Yuxi Luo; Yunwei Liu

Subjects: IL-6; Tocilizumab; Immune checkpoint inhibitors

• Source: Cancer Immunology, Immunotherapy, Vol 74, Iss 2, Pp 1-18 (2025)

Record details

Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study

• Authors : Zhiliang Guo; Rula Sa; Daqiang Zhao

Subjects: Antibody-mediated rejection; Donor-specific antibody; Daratumumab

• Source: BMC Nephrology, Vol 26, Iss 1, Pp 1-11 (2025)

Record details